Federal Supply Schedule 36F79726D0048
Award Date 12/15/25
Last Date to Order 12/14/30
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Federal Supply Schedule contract represents an interim agreement under GSA Schedule 65, Section I.B, covering drugs, pharmaceuticals, and hematology-related products. The award was made to Nuvation Bio, Inc. (UEI: ZF4GX9YEQE24) on July 18, 2025, with a contract ceiling value of $25,000.00 and an ultimate completion date of December 14, 2025. The contract was awarded without a set-aside restriction on a multiple award basis, indicating that other contractors may hold similar agreements under...
- Bioxcel Therapeutics, Inc. (UEI: KRNFT2F99W76) was awarded a multiple award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract, awarded on February 15, 2023, carries a ceiling value of $2,225,000 and is set to expire on February 14, 2028. This General Services Administration schedule contract establishes a framework for the supply of...
- Neurotech Pharmaceuticals, Inc. (UEI: SSYBDBA61GV4) was awarded a multiple-award Federal Supply Schedule contract effective January 1, 2026, through December 31, 2030, with a ceiling value of $225,000. The contract was awarded under General Services Administration schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The funding agency is the Veterans Integrated Service Network 12, a civilian component of the Department of Veterans Affairs responsible for providing...
- Medunik USA Inc. (UEI: DND9H4EQ14T5) has been awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract carries a ceiling value of $3,000,000 and was awarded on September 1, 2025, with an ultimate completion date of August 31, 2030, representing a...
- Supernus Pharmaceuticals, Inc. (UEI: YGWZHL8KYAM8) was awarded a Federal Supply Schedule 65-IB multiple award contract on September 15, 2022, by Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract, with a ceiling value of $132.6 million and an ultimate completion date of September 14, 2027, establishes a vehicle for the supply of drugs, pharmaceuticals, and hematology-related products to Veterans Affairs medical facilities and...
- Verona Pharma, Inc. (UEI: JB17M46E2YS9) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. This contract award, effective March 15, 2025, covers drugs, pharmaceuticals, and hematology-related products and services under Federal Supply Group 65, Item Class 1B. The contract carries a ceiling value of...
- Intra-Cellular Therapies, Inc. (UEI: VA5JXLCJHDK7) was awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on October 1, 2020, with an ultimate completion date of September 30, 2026. This multiple-award contract, funded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency component of the Department of Veterans Affairs, carries a ceiling value of $24,000,000. The contract was issued on a non-set-aside basis and includes a...
- Acrotech Biopharma Inc. (UEI: DN63NKTYLF33) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule on February 15, 2020, to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract carries a ceiling value of $225,000 and extends through February 14, 2026. This Federal Supply Schedule contract...
- ONY Biotech Inc. (UEI: L3ZJABL49BB8) was awarded a multiple-award Federal Supply Schedule contract on March 15, 2017, for the provision of drugs, pharmaceuticals, and hematology-related products under General Services Administration schedule 65 IB. The indefinite delivery vehicle carries a ceiling value of $294,760.00 and remains effective through March 14, 2026. The contract incorporates Public Law 102-585 pricing provisions with dual pricing structures and was awarded without set-asides. The...
- Accord Biopharma, Inc. (UEI: M3PMHL5VML74) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on December 15, 2022, to supply drugs, pharmaceuticals, and hematology-related products to the Department of Veterans Affairs, specifically Veterans Integrated Service Network 12. This contract was issued without a set-aside designation and carries a ceiling value of $300,000.00, with an ultimate completion date of December 14, 2027. As...